Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-06-14
1992-12-29
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Lymphokine
4352351, 4353201, 424 93, 935 32, 935 57, 935 65, A61K 39295, A61K 39275, C12N 701, C12N 1586
Patent
active
051749939
ABSTRACT:
The present invention provides a method for inducing an immunological response in a vertebrate to a pathogen by inoculating the vertebrate with a synthetic recombinant avipox virus modified by the presence, in a non-essential region of the avipox genome, of DNA from any source which codes for and expresses an antigen of the pathogen. The present invention further provides a synthetic recombinant avipox virus modified by the insertion therein of DNA from any source, and particularly from a non-avipox source, into a non-essential region of the avipox genome.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4663281 (1987-05-01), Gillies et al.
patent: 4722848 (1988-02-01), Paoletti et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4738846 (1988-04-01), Rose et al.
patent: 4769330 (1988-09-01), Paoletti et al.
Babinet, C. et al. 1985. Science vol. 230 pp. 1160-1163.
Ballay, A. et al 1985. The EMBO Journal vol. 4 pp. 3861-3865.
Salter, D. W. et al. 1987. Virology vol. 157 pp. 236-240.
Watanabe, S. et al. 1983. Molecular and Cellular Biology vol. 3 pp. 2241-2249.
Mann, R. et al. 1983. Cell vol. 33 pp. 153-159.
Schachter, J. 1980. In Manual of Clinical Microbiology 3rd ed. E. H. Lennette et al, American Society for Microbiology, pp. 357-364. H. R. 1984. Biological Abstr. vol. 77 p. 402 Abstr. 3598.
Langridge, W. H. R. 1984. Biological Abstr. vol. 77 p. 402 Abstr. 3598.
Nakano et al Proc. Natl. Acad Sci vol. 79 (1982) pp. 1593-1596.
Smith et al, Proc. Natl. Acad Sci vol. 80 (1983) 7155-7159.
Pouwells et al Cloning Vectors (1985) pVIII-A-a-i-9.
Graham, Tibtech 8, 85-87 (Apr., 1990).
Prevec et al., J. gen. Virol. 70, 429-434 (1989).
Tartaglia et al., Immunochemistry of Viruses II, edited by M. H. V. van Regenmortel et al. (Elsevier Science Publishers), 125-151 (1990).
Melnick, Virology, Second Edition, edited by B. N. Fields (Raven Press, N.Y.), Chapter 21, 549-605 1990).
Kitson et al., J. Virol. 65, 3068-3075 (1991).
Hagino-Yamagishi, Chapter 14, New Aspects of Positive-Strand RNA Viruses (American Society for Microbiology, Washington, D.C.), edited by M. A. Brinton et al.
Hagino-Yamagishi et al., J. Virol. 63, 5386-5392 (1989).
Choi et al., J. Virol. 65, 2875-2883 (1991).
Geigenmuller-Gnirke et al., Proc. Natl. Acad. Sci. U.S.A. 88, 3253-3257 (1991).
Levis et al., J. Virol. 64, 1726-1733 (1990).
Pattnaik et al., Proc. Natl. Acad. Sci. U.S.A. 88, 1379-1383 (1991).
Pattnaik et al., J. Virol 64, 2948-2957 (1990).
Huang et al., J. Virol. 64, 5669-5673 (1990).
Wild et al., Vaccine 8, 441 (1991).
Boursnell et al., Virus Research 1, 303-313 (1984).
Paoletti et al., Proc. Natl. Acad. Sci. USA 81, 193-197 (1984).
Chemical Abstracts 72095k.
Biological Abstracts 3809.
Chemical Abstracts 103510m.
Chemical Abstracts 133233q.
Fenner et al. (1987) In: Veterinary Virology, Academic Press, pp. 403-404.
Bruner, D. W. (1963) The pox diseases of man and animals. In: Diseases Transmitted from Animals to Man, (ed. Hull, T. G.), Charles C. Thomas, Publisher p. 394.
Lyles et al. (1976) Cellular fatty acids during fowlpox virus infection of three different host systems, Virology70, p. 227.
Classification and Nomenclature of Viruses, Intervirology 17, p. 43.
Beveridge, W. I. B. and L. Hart (1985) Animal Health in Australia, vol. 7, p. 58.
Gillespie, J. H. and J. F. Timoney (1981) Hagan and Bruner's Infectious Dieases of Domestic Animals. Cornell University Press, p. 531.
Buxton, A. (1977) Animal Microbiology. Blackwell Scientific Publications, p. 693.
Andrewes et al. (1978) Viruses of Vertebrates. Cassell & Co. Ltd, p. 374.
Hofstad et al. (1972) Diseases of Poultry. The Iowa University Press, p. 707.
Rhodes, A. J. and C. E. Van Rooyen (1968) Textbook of Virology. The Williams and Wilkins Co.
Merck Veterinary Manual (1986) ed. Fraser et al., p. 1324.
Dalrymple, J. M. (1989) Vaccinia-vectored vaccines for exotic disease immunization programmes. In: Vaccinia-vectored Vaccines-Risks and Benefits, (ed. F. A. Murphy), 2nd Forum in Virology, Institut Pasteur, Elsevier, p. 479.
Esposito, J. J. and F. A. Murphy (1989) Infectious recombinant vectored virus vaccines. In: Vaccine Biotechnology, vol. 33 (ed. Bittle, J. L. and F. A. Murphy), Academic Press, p. 235.
Mackett, M. and G. L. Smith (1986) Vaccinia virus expression vectors, J. gen Virol. 67, p. 2078.
Health Research , Inc.
Mosher Mary E.
Schwartz Richard A.
LandOfFree
Recombinant avipox virus and immunological use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant avipox virus and immunological use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant avipox virus and immunological use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1885870